Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 16, 2015 08:00 ET | Source: Alcobra Ltd.

Alcobra Ltd. to Release First Quarter 2015 Financial Results and Host Corporate Update Conference Call & Webcast on May 6

TEL AVIV, Israel, April 16, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
April 06, 2015 08:00 ET | Source: Alcobra Ltd.

Alcobra Ltd. to Present at Two CNS Focused Conferences in April

TEL AVIV, Israel, April 6, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
March 10, 2015 08:00 ET | Source: Alcobra Ltd.

Alcobra's MDX Meets Primary Endpoint in Phase II Safety and Tolerability Clinical Trial in Adolescents With ADHD

TEL AVIV, Israel, March 10, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
March 03, 2015 08:00 ET | Source: Alcobra Ltd.

Alcobra Ltd. to Present at 27th Annual ROTH Conference

TEL AVIV, Israel, March 3, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
February 12, 2015 07:30 ET | Source: Alcobra Ltd.

Alcobra Announces Fourth Quarter and Fiscal Year 2014 Financial Results and Provides Corporate Update

Conference Call & Webcast at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time TEL AVIV, Israel, Feb. 12, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical...
February 02, 2015 08:00 ET | Source: Alcobra Ltd.

Alcobra Ltd. to Release Fourth Quarter and Fiscal Year 2014 Financial Results and Host Corporate Update Conference Call & Webcast on February 12

TEL AVIV, Israel, Feb. 2, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
January 29, 2015 08:11 ET | Source: Alcobra Ltd.

Alcobra Ltd. to Present at BIO CEO & Investor Conference

TEL AVIV, Israel, Jan. 29, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
January 14, 2015 09:00 ET | Source: Alcobra Ltd.

Alcobra Ltd. Announces Closing of Public Offering of Ordinary Shares and Full Exercise of Over-Allotment Option

TEL AVIV, Israel, Jan. 14, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD) today reported that it has closed its previously announced public offering of ordinary shares. The Company sold 7,475,000...
January 09, 2015 09:06 ET | Source: Alcobra Ltd.

Alcobra Ltd. Prices Public Offering of Ordinary Shares

TEL AVIV, Israel, Jan. 9, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD) announced the pricing of its previously announced underwritten public offering of 6,500,000 ordinary shares at an offering...
January 08, 2015 16:19 ET | Source: Alcobra Ltd.

Alcobra Ltd. Announces Commencement of Public Offering of Ordinary Shares

TEL AVIV, Israel, Jan. 8, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD) announced today that it intends to offer its ordinary shares in an underwritten public offering. The offering is subject...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right